Amerigo Scientific announced the availability of its comprehensive portfolio of 3D bioprinters and biomaterials.


NEW YORK, NY, November 20, 2025 /24-7PressRelease/ -- Amerigo Scientific is a leading supplier dedicated to providing key products and services for the biomedical and life sciences fields. Today, the company announced the launch of its comprehensive 3D bioprinter and biomaterial product portfolio, which includes 3D printers based on extrusion technology and a wide range of high-performance bioinks, enabling scientists to break through the boundaries of tissue engineering and create 3D models with greater physiological relevance.

The combination of advanced biological printing hardware and professional materials is crucial for replicating the complex microenvironment of human tissues. Amerigo Scientific's 3D bioprinting products offer an end-to-end solution, allowing researchers to precisely and reproducibly design, prototype, and construct functional 3D tissues.

"Our mission is to equip researchers with the innovative tools they need to make groundbreaking discoveries," said a spokesperson for Amerigo Scientific. "By offering this integrated ecosystem of 3D bioprinters and complementary biomaterials, we are lowering the barrier to entry for complex 3D biology work and accelerating the path from basic research to therapeutic applications."

Amerigo Scientific's 3D Bioprinter Portfolio: Precision and Flexibility
The line of 3D bioprinters is engineered for reliability and ease of use in a lab setting. These systems are designed to handle a variety of bioinks and printing techniques, allowing for printing several materials in one session. Key features of the 3D bioprinters include:

• Multi-Material Printing: Capable of printing with different materials simultaneously (synthetic polymers, cellular aggregates, microcarriers, etc.), enabling the creation of intricate, heterogeneous tissue constructs.

• Advanced Extrusion Control: Precise pneumatic and screw-driven extrusion systems ensure high cell viability and accurate deposition of sensitive biological materials.

• High-standard biomaterials: To complement the bioprinting hardware, Amerigo Scientific also offers an extensive selection of biomaterials and bioinks. These materials are thoroughly tested by academia and the tissue engineering industry, proven to yield the best biological results.

Amerigo Scientific's 3D bioprinting products are poised to accelerate research in critical areas, including:
• Drug Discovery and Development: Creating more predictive 3D tissue models for high-throughput toxicity testing and efficacy screening.

• Regenerative Medicine: Engineering patient-specific tissue grafts and scaffolds for wound healing and organ repair.

• Cancer Research: Modeling the complex tumor microenvironment to study cancer progression and test novel oncology therapeutics.

The full portfolio of 3D bioprinters and biomaterials is available for order immediately through Amerigo Scientific. For more information, to request a quote, or to speak with a product specialist, visit www.amerigoscientific.com.

About Amerigo Scientific
Amerigo Scientific is a trusted global partner and distributor, providing essential reagents, instruments, and services to the biomedical and life science sectors. Committed to empowering scientific advancement, the company offers a vast portfolio of high-quality products, including those for cell and gene therapy, molecular diagnostics, and now, advanced 3D bioprinting. Amerigo Scientific is dedicated to supporting researchers with reliable tools and exceptional customer service to help them achieve their scientific goals.

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]



For the original version on 24-7 Press Release Newswire visit: